Dr. Jose Baselga highlights exciting studies at the American Association for Cancer Research (AACR) Annual 2012 meeting in Chicago. Jose Baselga, MD, PhD is the Chief of the Division of Hematology/Oncology, Associate Director of the Massachusetts General Hospital Cancer Center and a Professor, Department of Medicine, Harvard Medical School. The Group Room at the American [...]

Dr. Jose Baselga gives an Pi3 Kinase Inhibitor update  for breast cancer patients at the American Association for Cancer Research (AACR) Annual 2012 meeting in Chicago. Jose Baselga, MD, PhD is the Chief of the Division of Hematology/Oncology, Associate Director of the Massachusetts General Hospital Cancer Center and a Professor, Department of Medicine, Harvard Medical [...]

  Dr. Jose Baselga discusses the exciting data for the HER2-negative breast cancer patient — the BOLERO-2 trial released at the CTRC-AACR 34th Annual San Antonio Breast Cancer Symposium. Dr. Baselga is the Chief of the Division of Hematology/Oncology, Associate Director of the Massachusetts General Hospital Cancer Center and a Professor, Department of Medicine, Harvard [...]

  Dr. Jose Baselga discusses the exciting data for the HER2-positive breast cancer patient — the CLEOPATRA trial released at the CTRC-AACR 34th Annual San Antonio Breast Cancer Symposium. Dr. Baselga is the Chief of the Division of Hematology/Oncology, Associate Director of the Massachusetts General Hospital Cancer Center and a Professor, Department of Medicine, Harvard [...]